Literature DB >> 6167568

Recognition of nucleophile-treated alpha 2-macroglobulin by the alveolar macrophage alpha-macroglobulin . protease complex receptor.

J Kaplan, F A Ray, E A Keogh.   

Abstract

Rabbit alveolar macrophages exhibit high affinity surface receptors which recognize alpha 2-macroglobulin . protease complexes but not native alpha 2- macroglobulin. Binding of alpha 2-macroglobulin . protease complexes to surface receptors is independent of the protease used to form the complex. In this communication, we demonstrate that treatment of human alpha 2-macroglobulin with nucleophilic agents (methyl amine, ammonium salts) converts native alpha 2-macroglobulin into a form recognized by the surface receptor for alpha 2-macroglobulin protease complexes. Analysis of the concentration dependency of ligand binding revealed that the surface receptor did not distinguish between nucleophile-treated alpha 2-macroglobulin and alpha 2-macroglobulin . protease complexes. These results are consistent with the hypothesis that proteases or nucleophilic agents effect the hydrolysis of an internal thiol-ester bond (Tack, B. F., Harrison, R. A., Janatova, J., Thomas, M. L., and Prahl, J. W. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 5764-5768), leading to an alteration in alpha 2-macroglobulin conformation. The altered conformation results in recognition of the alpha 2-macroglobulin by surface receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167568

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The rate of internalization of different receptor-ligand complexes in alveolar macrophages is receptor-specific.

Authors:  D M Ward; J Kaplan
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

2.  Alpha-macroglobulins: enzyme-binding proteins modulating lymphocyte function.

Authors:  D Ganea; S Dray; M Teodorescu
Journal:  Surv Immunol Res       Date:  1983

3.  Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma.

Authors:  Amy R Wyatt; Nathan W Zammit; Mark R Wilson
Journal:  Cell Stress Chaperones       Date:  2012-08-16       Impact factor: 3.667

4.  The structure of alpha 2-macroglobulin-methylamine after papain digestion as determined by electron microscopy.

Authors:  I M Hussaini; N L Figler; S L Gonias
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

5.  Probing the stability of native and activated forms of alpha2-macroglobulin.

Authors:  Steven J Kaczowka; Lara S Madding; Kevin L Epting; Robert M Kelly; George J Cianciolo; Salvatore V Pizzo
Journal:  Int J Biol Macromol       Date:  2007-10-07       Impact factor: 6.953

6.  Role of the scavenger receptor in the uptake of methylamine-activated alpha 2-macroglobulin by rat liver.

Authors:  M C van Dijk; W Boers; C Linthorst; T J van Berkel
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

7.  Human leukocyte elastase, cathepsin G, and lactoferrin: family of neutrophil granule glycoproteins that bind to an alveolar macrophage receptor.

Authors:  E J Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Evidence for similar conformational changes in alpha 2-macroglobulin on reaction with primary amines or proteolytic enzymes.

Authors:  I Björk; W W Fish
Journal:  Biochem J       Date:  1982-11-01       Impact factor: 3.857

9.  Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors.

Authors:  S L Gonias; A E Balber; W J Hubbard; S V Pizzo
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

10.  The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin.

Authors:  J D Ashcom; S E Tiller; K Dickerson; J L Cravens; W S Argraves; D K Strickland
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.